INTRAVESICAL α-RADIOIMMUNOTHERAPY OF HUMAN UROTHELIAL CARCINOMA IN AN ORTHOTOPIC XENOGRAFT MOUSE MODEL: A PROMISING NEW THERAPY FOR SUPERFICIAL BLADDER CANCER

被引:0
作者
Autenrieth, M. [1 ]
Pfost, B. [2 ]
Seidl, C. [2 ]
Treiber, U. [1 ]
Gschwend, J. E. [1 ]
Senekowitsch-Schmidtke, R. [2 ]
机构
[1] Tech Univ Munich, Rechts Isar Med Ctr, Dept Urol, Munich, Germany
[2] Tech Univ Munich, Rechts Isar Med Ctr, Dept Nucl Med, Munich, Germany
关键词
D O I
10.1016/S1569-9056(10)60910-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:292 / 292
页数:1
相关论文
共 50 条
[21]   ENHANCED ANTITUMOR EFFECT OF INTRAVESICAL BCG PLUS DOCETAXEL THERAPY IN AN ORTHOTOPIC BLADDER CANCER MODEL [J].
Horinaga, Minoru ;
Fukuyama, Ryuichi ;
Iida, Masahiro ;
Matsushima, Masashi ;
Yanaihara, Hitoshi ;
Nakahira, Yoko ;
Ueno, Munehisa ;
Asakura, Hirotaka .
JOURNAL OF UROLOGY, 2011, 185 (04) :E212-E212
[22]   Intravesical anti-PD-1 immune checkpoint inhibition in urothelial bladder cancer in a mouse model [J].
Rajkumar, Anne ;
Wang, Jian ;
Neuzil, Kevin E. ;
Kirschner, Austin Noah ;
Chang, Sam S. .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
[23]   EXPERIMENTAL INTRAVESICAL THERAPY FOR SUPERFICIAL TRANSITIONAL CELL-CARCINOMA IN A RAT BLADDER-TUMOR MODEL [J].
STEINBERG, GD ;
BRENDLER, CB ;
SQUIRE, RA ;
ISAACS, JT .
JOURNAL OF UROLOGY, 1991, 145 (03) :647-653
[24]   Preclinical Evaluation of Transcriptional Targeting Strategy for Human Hepatocellular Carcinoma in an Orthotopic Xenograft Mouse Model [J].
Sia, Kian Chuan ;
Huynh, Hung ;
Chung, Alexander Yaw Fui ;
Ooi, London Lucien Peng Jin ;
Lim, Kiat Hon ;
Hui, Kam Man ;
Lam, Paula Yeng Po .
MOLECULAR CANCER THERAPEUTICS, 2013, 12 (08) :1651-1664
[25]   Enhanced Antitumor Effect of Coincident Intravesical Gemcitabine Plus BCG Therapy in an Orthotopic Bladder Cancer Model [J].
Horinaga, Minoru ;
Fukuyama, Ryuichi ;
Iida, Masahiro ;
Yanaihara, Hitoshi ;
Nakahira, Yoko ;
Nonaka, Shoichi ;
Deguchi, Nobuhiro ;
Asakura, Hirotaka .
UROLOGY, 2010, 76 (05) :1267.e1-1267.e6
[26]   ENHANCED ANTITUMOR EFFECT OF INTRAVESICAL BCG PLUS MMC THERAPY IN AN ORTHOTOPIC MURINE BLADDER CANCER MODEL [J].
Horinaga, Minoru ;
Matsushima, Masashi ;
Fukuyama, Ryuichi ;
Yanaihara, Hitoshi ;
Iida, Masahiro ;
Nakahira, Yoko ;
Asakura, Hirotaka .
JOURNAL OF UROLOGY, 2010, 183 (04) :E445-E445
[27]   ENHANCED ANTITUMOR EFFECT OF INTRAVESICAL GEMICITABINE THERAPY PLUS BCG IN AN ORTHOTOPIC MURINE BLADDER CANCER MODEL [J].
Horinaga, Minoru ;
Fukuyama, Ryuichi ;
Iida, Masahiro ;
Yanaihara, Hitoshi ;
Nakahira, Yoko ;
Nonaka, Syoichi ;
Deguchi, Nobuhiro .
JOURNAL OF UROLOGY, 2009, 181 (04) :408-408
[28]   Enhanced antitumor effect of combination intravesical BCG plus Docetaxel therapy in an orthotopic bladder cancer model [J].
Horinaga, Minoru ;
Fukuyama, Ryuichi ;
Iida, Masahiro ;
Matsushima, Masashi ;
Yanaihara, Hiroshi ;
Nakahira, Yoko ;
Ueno, Munehisa ;
Asakura, Hirotaka .
CANCER RESEARCH, 2011, 71
[29]   THE DEVELOPMENT OF LIPOSOMES CONTAINING INTERFERON-ALPHA FOR THE INTRAVESICAL THERAPY OF HUMAN SUPERFICIAL BLADDER-CANCER [J].
FRANGOS, DN ;
KILLION, JJ ;
FAN, D ;
FISHBECK, R ;
VONESCHENBACH, AC ;
FIDLER, IJ .
JOURNAL OF UROLOGY, 1990, 143 (06) :1252-1256
[30]   Intravesical Anti-PD-1 Immune Checkpoint Inhibition Treats Urothelial Bladder Cancer in a Mouse Model [J].
Kirschner, Austin N. ;
Wang, Jian ;
Rajkumar-Calkins, Anne ;
Neuzil, Kevin E. ;
Chang, Sam S. .
JOURNAL OF UROLOGY, 2021, 205 (05) :1336-1343